STP & Pharmacogénétique - 1
mardi 24 juin 2025
Sessions parallèles
Sessions parallèles
•
S22
•
16h45
>
18h15
•
STP & Pharmacogénétique - 1
•
IFPS - Amphi 2
Sessions parallèles
Modératrices : Françoise GOIRAND (Dijon), Marie-Clémence VERDIER (Rennes)
Conférence invitée
16h45 Inhibiteurs JAK: nouveaux candidats au STP ? - François GIRARDIN (Suisse)
Communications orales
•
83
•
CO-025 - Leveraging synthetic data to address data sharing challenges in pharmacometrics: case studies with simulated and real data
>
A.
Alexandre
Destere
•
95
•
CO-026 - Cefazolin population pharmacokinetics in children undergoing maintenance hemodialysis for kidney failure
>
R.
Romain
Berthaud
•
231
•
CO-027 - Optimization of cefotaxime treatment in intensive care patients: impact of inter- and intra-patient variability on pharmacokinetics and target attainment
>
A.
Anthéa
Deschamps
•
188
•
CO-028 - Optimization of beta-lactams treatment in intensive care patients using Therapeutic Drug Monitoring (TDM): a prospective, comparative, interventional study.
>
R.
Romain
Guilhaumou
•
53
•
CO-029 Benefits of implementing a sensitive and specific urinary screening method (High Resolution Liquid Chromatography-High Resolution Mass Spectrometry – LC-HRMS) for psychoactive substances and drugs in the management of patients hospitalized in an addiction unit
>
M.
Mélanie
Duval
•
72
•
CO-030 - Could iohexol clearance predict glomerular filtration rate in living kidney donor one-year after donation?
>
C.
Capucine
Arrivé
|